Viewing Study NCT04952805


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2025-12-26 @ 2:00 AM
Study NCT ID: NCT04952805
Status: UNKNOWN
Last Update Posted: 2022-02-03
First Post: 2021-07-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.
Sponsor: Toscana Life Sciences Sviluppo s.r.l.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-06
Start Date Type: ACTUAL
Primary Completion Date: 2022-03-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2022-08-31
Completion Date Type: ESTIMATED
First Submit Date: 2021-07-01
First Submit QC Date: None
Study First Post Date: 2021-07-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-02-02
Last Update Post Date: 2022-02-03
Last Update Post Date Type: ACTUAL